Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Leica Microsystems' US Acquisition Expands Histopathology Range

By Labmedica staff writers
Posted on 19 May 2008
In a move that further advances its strong global position in the histopathology field, Leica Microsystems announced the acquisition of the assets of US-based Coretech Holdings. More...
The acquired concern is to become a business unit within Leica Microsystems' Biosystems Division, and will be renamed Leica Biosystems St. Louis, LLC. Terms of the transaction were not disclosed.

Composed of a group of strong brands including McCormick Scientific, The Vibratome Company, Paraplast embedding media, TurbOflow II histology cassettes and myNeuroLab.com, Coretech (St. Louis, MO, USA) provides an extensive range of systems, instruments, reagents, and consumables for the clinical and research histology laboratory.

According to Doug Martin, formerly CEO of Coretech Holdings and now Vice President & General Manager of Leica Biosystems St. Louis, LLC, The synergies created by combining the Coretech products and team with those of Leica Microsystems are considerable. Both companies will quickly leverage an improved product offering for our customers and expand our ability to service their needs.

Anne De Greef-Safft, President of Leica Microsystems' Biosystems Division added, With this acquisition, Leica Microsystems continues to broaden and strengthen the product line we offer our customers. The benefit to customers is that they now have a single partner to come to for all their histology equipment, reagent, and consumable needs. Having internal R&D, as well as manufacturing capabilities for the instrument and their associated reagents and consumables allows us to better optimize the entire system, leading to higher quality and more consistent results for our customers.

Leica Microsystems (Wetzlar, Germany) is a leading global developer and producer of precision optical systems for the analysis of microstructures. The company manufactures a broad range of products requiring microscopic imaging, measurement, and analysis, and offers system solutions for life sciences including biotechnology and medicine, R&D of raw materials, and industrial quality assurance. Leica Microsystems is represented in over 100 countries with 9 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers.


Related Links:
Coretech
Leica Microsystems

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.